Literature DB >> 16596125

EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.

Jonathan E Dowell1, John D Minna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596125     DOI: 10.1038/ncponc0476

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


× No keyword cloud information.
  6 in total

Review 1.  Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance.

Authors:  Kimmo J Hatanpaa; Sandeep Burma; Dawen Zhao; Amyn A Habib
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

2.  Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling.

Authors:  Robert Borkowski; Liqin Du; Zhenze Zhao; Elizabeth McMillan; Adam Kosti; Chin-Rang Yang; Milind Suraokar; Ignacio I Wistuba; Adi F Gazdar; John D Minna; Michael A White; Alexander Pertsemlidis
Journal:  Cancer Res       Date:  2014-12-17       Impact factor: 12.701

3.  Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis study.

Authors:  Ricardo S Macarenco; Timothy S Uphoff; Heather Flynn Gilmer; Robert B Jenkins; Stephen N Thibodeau; Jean E Lewis; Julian R Molina; Ping Yang; Marie-Christine Aubry
Journal:  Mod Pathol       Date:  2008-06-27       Impact factor: 7.842

4.  TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer.

Authors:  Ke Gong; Gao Guo; David E Gerber; Boning Gao; Michael Peyton; Chun Huang; John D Minna; Kimmo J Hatanpaa; Kemp Kernstine; Ling Cai; Yang Xie; Hong Zhu; Farjana J Fattah; Shanrong Zhang; Masaya Takahashi; Bipasha Mukherjee; Sandeep Burma; Jonathan Dowell; Kathryn Dao; Vassiliki A Papadimitrakopoulou; Victor Olivas; Trever G Bivona; Dawen Zhao; Amyn A Habib
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

5.  Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer.

Authors:  Corey Speers; Anna Tsimelzon; Krystal Sexton; Ashley M Herrick; Carolina Gutierrez; Aedin Culhane; John Quackenbush; Susan Hilsenbeck; Jenny Chang; Powel Brown
Journal:  Clin Cancer Res       Date:  2009-10-06       Impact factor: 12.531

6.  Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma.

Authors:  Michelle Levy; Liisa Lyon; Erika Barbero; John Wong; Marie Suga; Danny Sam; Minggui Pan
Journal:  Med Sci (Basel)       Date:  2017-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.